Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Carnosol delays chemotherapy-induced DNA fragmentation and morphological changes associated with apoptosis in leukemic cells
Nutrition and Cancer, 01/12/09
Zunino SJ et al. – Findings show that carnosol (from the herb rosemary) blocks terminal apoptotic events induced by chemotherapeutic drugs and suggest that increased dietary carnosol may decrease effectiveness of some standard chemotherapy treatments used for leukemia.
Methods- Study of carnosol for its ability to sensitize leukemia cells to chemotherapeutic agents
- Analysis of DNA strand breaks by terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling
- Time course analysis of caspase-3 activation by flow cytometry
- Carnosol reduced cell death in the pre-B acute lymphoblastic leukemia (ALL) lines SEM, RS4;11, and REH when combined with cytarabine, methotrexate, or vincristine vs chemotherapeutic agents alone
- Carnosol delayed DNA cleavage when combined with chemotherapeutic drugs
- Co-treatment of cells with carnosol and chemotherapeutic drugs did not reduce mitochondrial membrane depolarization vs drug treatment alone
- Cotreatment with carnosol and drugs increased activation of caspase-3 vs chemotherapeutic drugs alone
- Fewer caspase-3 positive cells progressed to an apoptotic phenotype when co-treated with carnosol and chemotherapeutic drugs vs drugs alone
Today in Alternative Therapies...keeping you current
Receive free subspecialty "5-minute updates" via email
A phase 2 trial exploring the effects of high-dose (10,000 IU/day) Vitamin D3 in breast cancer patients with bone metastases
Cancer, 11/18/09
Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions
Cancer Prevention Research, 11/09/09
Oral Cancer Prevention Advances with a Translational Trial of Green Tea
Cancer Prevention Research, 11/11/09
Today in Leukemia/Lymphoma...keeping you current
Receive free subspecialty "5-minute updates" via email
Hodgkin's lymphoma in remission after first-line therapy: Which patients need FDG-PET/CT for follow-up?
Annals of Oncology, 11/17/09
Comparison of neurocognitive functioning in children previously randomly assigned to intrathecal methotrexate compared with triple intrathecal therapy for the treatment of childhood acute lymphoblastic leukemia
Journal of Clinical Oncology, 11/09/09
Primary extranodal marginal zone lymphoma of the uvea associated with massive diffuse epibulbar extension and focal infiltration of the optic nerve and meninges, clinically presented as uveitis masquerade syndrome: a case report
Medical Oncology, 10/16/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


